RoNeuro Institute for Neurological Research and Diagnostic, Cluj Napoca, Romania.
Department of Neurosciences, Clinical County Emergency Hospital, Cluj Napoca, Romania.
Neurol Sci. 2024 Mar;45(3):911-940. doi: 10.1007/s10072-023-07144-6. Epub 2023 Oct 26.
TBS (theta-burst stimulation) is a novel therapeutic approach in a wide range of neurological diseases. The present systematic review aims to identify the various protocols used in the last years, to assess study quality and to offer a general overview of the current state of the literature. The systematic review was conducted according to the Preferred Reporting Item for Systematic Review and Meta-Analyses (PRISMA) guidelines. We applied the following inclusion criteria: (1) population over 18 years old with diagnosed neurological disorders, (2) patients treated with sessions of theta-burst stimulation, (3) randomized-controlled clinical trials, (4) articles in the English language, and (5) studies that report response and score reduction on a validated scale of the investigated disorder or remission rates. We included in the final analysis 56 randomized controlled trials focusing on different neurological pathologies (stroke, Parkinson`s disease, multiple sclerosis, tinnitus, dystonia, chronic pain, essential tremor and tic disorder), and we extracted data regarding study design, groups and comparators, sample sizes, type of coil, stimulation parameters (frequency, number of pulses, intensity, stimulation site etc.), number of sessions, follow-up, assessment through functional connectivity and neurological scales used. We observed a great interstudy heterogenicity that leads to a difficulty in drawing plain conclusions. TBS protocols have shown promising results in improving various symptoms in patients with neurological disorders, but larger and more coherent studies, using similar stimulation protocols and evaluation scales, are needed to establish guideline recommendations.
TBS(theta-burst stimulation)是一种广泛应用于神经科疾病的新型治疗方法。本系统综述旨在确定近年来使用的各种方案,评估研究质量,并提供当前文献的总体概述。系统综述按照系统评价和荟萃分析的首选报告项目(PRISMA)指南进行。我们应用了以下纳入标准:(1)年龄在 18 岁以上的患有诊断性神经疾病的患者,(2)接受 theta-burst 刺激治疗的患者,(3)随机对照临床试验,(4)英语文章,(5)报告经调查疾病的有效量表上的反应和评分降低或缓解率的研究。我们最终分析了 56 项针对不同神经病理学(中风、帕金森病、多发性硬化症、耳鸣、肌张力障碍、慢性疼痛、特发性震颤和抽动障碍)的随机对照试验,并提取了关于研究设计、组和对照组、样本量、线圈类型、刺激参数(频率、脉冲数、强度、刺激部位等)、治疗次数、随访、通过功能连接和神经量表进行评估的数据。我们观察到研究之间存在很大的异质性,这使得很难得出明确的结论。TBS 方案在改善神经障碍患者的各种症状方面显示出了有希望的结果,但需要更大、更一致的研究,使用类似的刺激方案和评估量表,以建立指南建议。